Executive summary of the Stages of Reproductive Aging Workshop + 10: addressing the unfinished agenda of staging reproductive aging Siobán D. Harlow,

Slides:

Advertisements

Similar presentations

Validation of a prediction model for the follicle-stimulating hormone response dose in women with polycystic ovary syndrome Madelon van Wely, Ph.D.,

Advertisements

The stages of Reproductive Aging Workshop +10 staging system for reproductive aging in women. (Reproduced with permission from Harlow SD, Gass M, Hall.

Effects of cancer treatment on ovarian function

Age at menarche: a predictor of diminished ovarian function?

Daily physical activity and hot flashes in the Study of Women's Health Across the Nation (SWAN) Flashes Study Carolyn Gibson, M.P.H., M.S., Karen Matthews,

Akanksha Mehta, M.D., Mark Sigman, M.D. Fertility and Sterility

Karl R. Hansen, M. D. , Ph. D. , George M. Hodnett, M. D

The relative effects of hormones and relationship factors on sexual function of women through the natural menopausal transition Lorraine Dennerstein,

Infertility evaluation and treatment among women in the United States

Fernando Zegers-Hochschild, M.D. Fertility and Sterility

The predictive value for in vitro fertility delivery rates is greatly impacted by the method used to select the threshold between normal and elevated.

Michael M. Alper, M.D. Fertility and Sterility

Janet Kwee, M. D. , Roel Schats, M. D. , Ph. D. , Joseph McDonnell, M

Administration of a gonadotropin-releasing hormone antagonist during the 3 days before the initiation of the in vitro fertilization/intracytoplasmic sperm.

Hysterosalpingography with use of mobile C-arm fluoroscopy

Dennis J. Hand, Ph. D. , Vanessa L. Short, Ph. D. , M. P. H. , Diane J

Hepatitis and reproduction

The luteal phase of recombinant follicle-stimulating hormone/gonadotropin-releasing hormone antagonist in vitro fertilization cycles during supplementation.

Growth rates of ovarian follicles during natural menstrual cycles, oral contraception cycles, and ovarian stimulation cycles Angela R. Baerwald, Ph.D.,

Ethnicity as a determinant of ovarian reserve: differences in ovarian aging between Spanish and Indian women Carlos Iglesias, M.D., Manish Banker, M.D.,

Can an educational DVD improve the acceptability of elective single embryo transfer? A randomized controlled study Nicole Hope, M.B., B.S., Hon., Luk.

Risk of depression and other mental health disorders in women with polycystic ovary syndrome: a longitudinal study Angela Kerchner, B.A., Whitney Lester,

Sanghoon Lee, M. D. , Elke Heytens, Ph. D. , Fred Moy, Ph. D

Temporal trends in clomiphene citrate use: a population-based study

Hakan Cakmak, M. D. , Audra Katz, R. N. , Marcelle I. Cedars, M. D

How old is too old? Challenges faced by clinicians concerning age cutoffs for patients undergoing in vitro fertilization Robert L. Klitzman, M.D. Fertility.

Randomized, controlled pilot trial of natural versus hormone replacement therapy cycles in frozen embryo replacement in vitro fertilization Ginny Mounce,

Reproduction at an advanced maternal age and maternal health

A Markov model of the cost-effectiveness of human-derived follicle-stimulating hormone (FSH) versus recombinant FSH using comparative clinical trial data

Improved monofollicular ovulation in anovulatory or oligo-ovulatory women after a low- dose step-up protocol with weekly increments of 25 international.

Oocyte cryopreservation

Prevalence of premature urinary luteinizing hormone surges in women with regular menstrual cycles and its effect on implantation of frozen-thawed embryos

Robert F. Casper, M.D. Fertility and Sterility

Mieke Carine Wim Eeckhaut, Ph.D. Fertility and Sterility

Influence of acupuncture stimulation on pregnancy rates for women undergoing embryo transfer Caroline Smith, Ph.D., Meaghan Coyle, B.Hlth.Sc. (Acup.),

Dynamic antimüllerian hormone levels during controlled ovarian hyperstimulation predict in vitro fertilization response and pregnancy outcomes Aaron.

Jennifer Lucero, M. D. , Bernard L Harlow, Ph. D

Menstrual cycle length is an age-independent marker of female fertility: results from 6271 treatment cycles of in vitro fertilization Thomas Brodin,

Executive summary: stages of reproductive aging workshop (STRAW)

Tomer Singer, M. D. , David H. Barad, M. D. , M. S

Management of tubal ectopic pregnancy: methotrexate and salpingostomy are preferred to preserve fertility Stephanie Beall, M.D., Ph.D., Alan H. DeCherney,

Clomiphene citrate at 50: the dawning of assisted reproduction

Feasibility of a brief, intensive weight loss intervention to improve reproductive outcomes in obese, subfertile women: a pilot study Amy Rothberg, M.D.,

Akanksha Mehta, M.D., Darius A. Paduch, M.D., Ph.D.

European view of subspecialty training on behalf of the European Society of Human Reproduction and Embryology (ESHRE) Carlos Calhaz-Jorge, M.D., Anis.

Tania Luisa Stevenson, M.B.Ch.B., Hany Lashen, F.R.C.O.G.

Effects of cancer treatment on ovarian function

Prospective cohort study of three- versus two-dimensional ultrasound for prediction of oocyte maturity Doron Shmorgun, M.D., Edward Hughes, M.D., Patrick.

Ri-Cheng Chian, Ph.D., Peter S. Uzelac, M.D., Geeta Nargund, M.D.

MaryFran Sowers, Ph. D. , Daniel McConnell, Ph. D

Effectiveness of highly purified human menopausal gonadotropin vs

Simvastatin improves biochemical parameters in women with polycystic ovary syndrome: results of a prospective, randomized trial Antoni J. Duleba, M.D.,

Fibroid growth and medical options for treatment

Website quality assessment: Mistaking apples for oranges

Pregnancy outcome in infertile patients with polycystic ovary syndrome who were treated with metformin Samuel S. Thatcher, M.D., Ph.D., Elizabeth M.

Fertility and Sterility: an evaluation

The menopausal transition

Moderately elevated levels of basal follicle-stimulating hormone in young patients predict low ovarian response, but should not be used to disqualify.

Validation of a prediction model for the follicle-stimulating hormone response dose in women with polycystic ovary syndrome Madelon van Wely, Ph.D.,

Association of endometriosis with body size and figure

Current evaluation of amenorrhea

Aline Ketefian, M. D. , Jianfang Hu, Ph. D. , Alfred A. Bartolucci, Ph

Comparing anti-Müllerian hormone (AMH) and follicle-stimulating hormone (FSH) as predictors of ovarian function David H. Barad, M.D., M.S., Andrea Weghofer,

In vitro sildenafil citrate use as a sperm motility stimulant

Soluble HLA-G in the peritoneal fluid of women with endometriosis

Progesterone level and progesterone/estradiol ratio on the day of hCG administration: detrimental cutoff levels and new treatment strategy Eman A. Elgindy,

Ovarian follicular volume and follicular surface area are better indicators of follicular growth and maturation, respectively, than is follicular diameter

Luisa Gonzalez, M.D., Selma Feldman Witchel, M.D.

Randomized, controlled pilot trial of natural versus hormone replacement therapy cycles in frozen embryo replacement in vitro fertilization Ginny Mounce,

P-24 Fertility and Sterility Volume 85, Pages S19-S20 (April 2006)

Presentation transcript:

Executive summary of the Stages of Reproductive Aging Workshop + 10: addressing the unfinished agenda of staging reproductive aging Siobán D. Harlow, Ph.D., Margery Gass, M.D., N.C.M.P., Janet E. Hall, M.D., Roger Lobo, M.D., Pauline Maki, Ph.D., Robert W. Rebar, M.D., Sherry Sherman, Ph.D., Patrick M. Sluss, Ph.D., Tobie J. de Villiers, M.B.Ch.B., F.R.C.O.G., F.C.O.G.(SA) Fertility and Sterility Volume 97, Issue 4, Pages 843-851 (April 2012) DOI: 10.1016/j.fertnstert.2012.01.128 Copyright © 2012 American Society for Reproductive Medicine Terms and Conditions

Figure 1 Adjusted population means (95% CI) for segmented mean profiles of follicle-stimulating hormone and estradiol across the final menstrual period in the Study of Women's Health Across the Nation (N = 1,215). ∗The y axis is unitless. The units of hormone are marked in the corresponding curves. Reproduced with permission from Randolph et al, J Clin Endocrinol Metab 2011;96:746–754. Fertility and Sterility 2012 97, 843-851DOI: (10.1016/j.fertnstert.2012.01.128) Copyright © 2012 American Society for Reproductive Medicine Terms and Conditions

Figure 2 The Stages of Reproductive Aging Workshop + 10 staging system for reproductive aging in women. Fertility and Sterility 2012 97, 843-851DOI: (10.1016/j.fertnstert.2012.01.128) Copyright © 2012 American Society for Reproductive Medicine Terms and Conditions